Paliperidone 3-Month Im Injection

Form: Once-3-Month IM Injection

Strength: 273 mg, 410 mg, 546 mg, 819 mg

Reference Brands: Trevicta®(EU); Invega Trinza®(US)

Category: Antipsychotropic Drugs

Paliperidone 3-month intramuscular injection (brand name: Invega Trinza) is FDA-approved in the United States for the maintenance treatment of schizophrenia in adults who have been stabilized on Invega Sustenna (1-month formulation) for at least four months. In the European Union, it is centrally approved by the EMA with established Risk Management Plans (RMPs) and required pharmacovigilance activities. Regulatory compliance includes GMP-certified long-acting injectable manufacturing, bridging pharmacokinetic and safety data, and documentation for relapse prevention. U.S. labeling includes a boxed warning for elderly patients with dementia-related psychosis. Explore dossier-ready options at Pharmatradz.com — your global B2B pharma hub.